Empresaria Group plc provided earnings guidance for the year ended December 31, 2015. For the year, the company expects adjusted profit before tax growth of approximately 23% year on year, with net fee income approximately 10% ahead of the prior year. Total net debt is expected to reduce by 26% from £9.8 million in 2014 to £7.3 million in 2015, which includes the term loan, as announced in October 2015, to help fund the acquisition of Pharmaceutical Strategies in the USA.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
39 GBX | 0.00% | -1.27% | +14.71% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.71% | 24.38M | |
+32.22% | 76.88B | |
+4.30% | 44.72B | |
-9.58% | 5.44B | |
+2.14% | 2.19B | |
-30.01% | 1.8B | |
+8.88% | 1.51B | |
+0.63% | 1.41B | |
-13.54% | 1.13B | |
-34.47% | 1.04B |
- Stock Market
- Equities
- EMR Stock
- News Empresaria Group plc
- Mpresaria Group plc Provides Earnings Guidance for the Year Ended December 31, 2015